// App-Quantinova.ai

84 P-3-750 : Oral Glucose Tolerance Test as a Routine Tool to Discriminate High Risk Individuals of Type 2 Diabetes in Child Obesity

Researchers

Presenter

  • Thomas Kintis

Principal Investigators

  • Staffan Marild

  • Jovanna Dahlgren

Medical Centers

  • GP-GRC, Inst for Clinical Sciences, Gothenburg, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Obesity

Biomarkers

  • Hemoglobin A1c

  • Interferon-gamma

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final